Medica 16
Grundinformationen
- CAS
87272-20-6- Standard-SMILES
CC(C)(CCCCCCCCCCC(C)(C)CC(=O)O)CC(=O)O- InChIKey
HYSMCRNFENOHJH-UHFFFAOYSA-N- Summenformel
- C20H38O4
- Durchschnittliche Molmasse
- 342,5 g/mol
- Monoisotopische Masse
- 342,27700969
Überblick
MEDICA 16 is an alpha,-dicarboxylic acid that is hexadecanedioic acid carrying methyl groups at positions 3 and 14. It is a free fatty acid 1 (FFA1/GPR40) receptor agonist and an ATP citrate lyase inhibitor, and exhibits hypolipidemic and antidiabetogenic properties. It has a role as an EC 2.3.3.8 (ATP citrate synthase) inhibitor, a hypoglycemic agent, an antilipemic drug, an EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor and a G-protein-coupled receptor agonist.
Namen und Bezeichner
- Bevorzugter Name
- Medica 16
- IUPAC
- 3,3,14,14-tetramethylhexadecanedioic acid
- Englischer Name
- MEDICA 16
- Summenformel
- C20H38O4
- Molmasse
- 342.51
Namen und Synonyme
MEDICA 1687272-20-63,3,14,14-Tetramethylhexadecanedioic acidMedic-16MEDICA-16TC257FLPCKCHEBI:149582DTXSID00236246RefChem:156225DTXCID00158737MEDICA16MFCD00797684
Weitere Namen anzeigen
MEDICA16, 10 mM in DMSO3,3,14,14-TETRAMETHYLHEXADECANEDIONIC ACIDACLY,antidiabetogenic,ATP Citrate Lyase,antidiabetic,skeletal,Inhibitor,MEDICA16,ligands,Free Fatty Acid Receptor,MEDICA-16,insulin,FFAR,endogenous,muscle,inhibit
CHEMBL638293,3,14,14-Tetramethyl-hexadecanedioic acidHexadecanedioic acid, 3,3,14,14-tetramethyl-SR-010009466653,3,14,14-Tetramethyl-hexadecane-1,16-dioic acid3,3,14,14-Tetramethylhexanedecanedioic acidUNII-TC257FLPCKHexadecandioic acid, 3,3,14,14-tetramethyl-
Datenbank-Bezeichner
- CAS
87272-20-6- PubChem CID
- 121871
- DTXSID
DTXSID00236246- ChEMBL
CHEMBL63829- ChEBI
CHEBI:149582- UNII
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 7
- Polarare Oberfläche (TPSA)
- 74,6 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 4
- Frei drehbare Bindungen
- 15
- Schwere Atome
- 24
- Formalladung
- 0
- Komplexität
- 336
Physikochemische Eigenschaften
- Schmelzpunkt
- 154 · 154-159 °C
- Siedepunkt
- 485.9 · 485.9±18.0 °C(Predicted)
- Dichte
- 0.984 · 0.984±0.06 g/cm3(Predicted)
- storage temp.
- 20 °C · −20°C
- Löslichkeit
- 28 mg/mL · DMSO: 28 mg/mL
- Aggregatzustand
- solid
- pka
- 4.51 · 4.51±0.10(Predicted)
- Farbe
- white
- InChI
- 1S/C20H38O4/c1-19(2,15-17(21)22)13-11-9-7-5-6-8-10-12-14-20(3,4)16-18(23)24/h5-16H2,1-4H3,(H,21,22)(H,23,24)
- InChIKey
- HYSMCRNFENOHJH-UHFFFAOYSA-N
- SMILES
- CC(C)(CCCCCCCCCCC(C)(C)CC(O)=O)CC(O)=O
Sicherheit und Regulatorisches
Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
Sicherheitsdaten
- wgk
- 3
- Speicherklasse
- 11 - Combustible Solids
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological ClassificationSubstances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS.
Anwendungen
BeschreibungMEDICA 16 is a β,β''-dimethyl hexadecanedioic acid which exhibits hypolipidemic and antidiabetogenic effects in the rat. In animals that were fed a diet which was 0.25% MEDICA 16 by weight, the hypolipidemic effect consisted of a 70-80% decrease in plasma chylomicrons and VLDL-triacylglycerols as well as a 40-60% decrease in plasma VLDL-cholestrol.
VerwendenMEDICA 16 is a β,β'-dimethyl hexadecanedioic acid which exhibits hypolipidemic and antidiabetogenic effects in the rat. In animals that were fed a diet which was 0.25% MEDICA 16 by weight, the hypolipidemic effect consisted of a 70-80% decrease in plasma chylomicrons and VLDL-triacylglycerols as well as a 40-60% decrease in plasma VLDL-cholestrol.
Anbieter30 Anbieter
Career Henan Chemica Co+86-0371-86658258 +86-13203830695 · [email protected]
北京穹峰科技有限公司13552142508 · [email protected]
北京博奥森生物技术有限公司400-901-9800 18611424007 · [email protected]
学研惠（武汉）科技有限公司15727060112 · [email protected]
吉林中科研伸科技有限公司18143011203 · [email protected]
BOC Sciences1-631-485-4226; 16314854226 · [email protected]
Zugehörige Reaktionen
2
Notizen zur Verbindung
Wird geladen…